Nov 17, 2026, 8:40 PMHealthcare
Private Equity Hospice Ownership Tied to Higher Medicare Costs and Longer Stays
New research finds private equity owned hospice providers have higher Medicare costs and longer patient stays, but the feed offers no further details.
Listen to this briefingAudio briefing
Summary
MarketWatch reported on November 17, 2026, that new research found higher Medicare costs and longer patient stays at hospice providers owned by private equity firms.
Only a short feed summary was available. It did not identify the researchers, private equity firms, hospice providers, sample size, methodology, cost or stay differences, study period, or any next steps, limiting assessment of the findings and their implications.
Positives
- New research gives investors evidence about Medicare costs and patient stays at private equity owned hospice providers.
- The findings address both a financial measure, Medicare costs, and a care utilization measure, patient stay length.
- The feed clearly states the direction of both findings, despite withholding their magnitude.
Risks & concerns
- Medicare costs were higher at hospice providers owned by private equity firms.
- Patients stayed longer at private equity owned hospice providers.
- The feed omitted the study methodology, sample, time period, measured differences, named firms, and provider identities.
Primary sourceMarketWatch.com - Top Storieshttps://www.marketwatch.com/story/private-equity-has-been-buying-up-hospice-centers-with-striking-consequences-63642545?mod=mw_rss_topstories
Read full article

